Edgewise Therapeutics Inc Financial Flexibility Index
Edgewise Therapeutics Inc financial flexibility index. Edgewise Therapeutics Inc (EWTX) has a Financial Flexibility Index of -1.67x as of March 2026. Free cash flow of $-42.28 Million (operating CF $-42.54 Million minus capex $260.00K) represents -2% of total liabilities ($25.32 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Edgewise Therapeutics Inc (2019–2025)
Financial flexibility index of Edgewise Therapeutics Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Edgewise Therapeutics Inc across 7 annual periods. Check cash flow quality index of Edgewise Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Edgewise Therapeutics Inc Financial Flexibility Index by Year (2019–2025)
Edgewise Therapeutics Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Edgewise Therapeutics Inc. For the full cash flow conversion analysis, see Edgewise Therapeutics Inc (EWTX) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.73x | $-143.56 Million | $-143.82 Million | $30.35 Million | ▼ -21.2% |
| 2024 | -3.90x | $-107.72 Million | $-109.03 Million | $27.60 Million | ▲ +4.0% |
| 2023 | -4.07x | $-86.20 Million | $-91.95 Million | $21.20 Million | ▼ -76.0% |
| 2022 | -2.31x | $-47.09 Million | $-52.63 Million | $20.39 Million | ▲ +23.7% |
| 2021 | -3.03x | $-32.84 Million | $-33.51 Million | $10.85 Million | ▼ -3351.3% |
| 2020 | -0.09x | $-14.43 Million | $-14.63 Million | $164.56 Million | ▲ +59.6% |
| 2019 | -0.22x | $-8.99 Million | $-9.17 Million | $41.39 Million | — |